Schemes of all sizes should employ straight through processing ahead of 2012 to ensure they are braced for the swathe of administration work which will follow auto-enrolment.

Some 4.5 million over-50s expect to work beyond their state retirement age, by an average of more than six years, LV= says.

EU plans to introduce Solvency II funding requirements to UK schemes face an "overwhelming tide of objection" and should be abandoned, lawyers say.

The Pensions Regulator felt it necessary to issue guidance on asset-backed funding structures and potential breaches of employer related investment rules this week.

It is wrong and "possibly illegal" for trustees to fully embrace The Pensions Regulator's stance on enhanced transfer value exercises, Raj Mody says.

Trustee boards should make sure their defined contribution scheme assets are given enough attention compared with defined benefit legacy section, delegates heard.

Conflict of interest faced by pensions managers is a critical issue which must be addressed but can be dealt with effectively, delegates heard.

UK - GlaxoSmithKline trustees have agreed a £900m ($1.4bn) buy-in deal with Prudential.

GlaxoSmithKline trustees have agreed a £900m buy-in deal with Prudential.

Low interest rates 'damaging pensions'